The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of tumor recurrence dynamics in patients with HR+/HER2- advanced breast cancer treated with ET+CDK4/6i: Results from the multicenter, Italian study PALMARES-2.
 
Claudio Vernieri
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Menarini Group; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Istituto Gentili; Lilly; Menarini Group; MSD; Novartis; Pfizer
Research Funding - Daiichi Sankyo/Astra Zeneca (Inst); Roche (Inst)
 
Roberta Caputo
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly Medical; MSD Oncology; Novartis; Pfizer; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer; Pierre Fabre
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Novartis
 
Maria Vittoria Dieci
Honoraria - AstraZeneca; daiichi-sankyo; Lilly; Menarini Group
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - AstraZeneca (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - reveal genomics - listed as co-inventor in patent applications for HER2DX
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Roche
 
Paolo Vigneri
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Incyte; Istituto Gentili; Lilly; Novartis; Pfizer; Roche; Seagen; Teva
 
Mario Giuliano
Stock and Other Ownership Interests - ADC Therapeutics; Aldeyra Therapeutics; BioAtla; Cardiff Oncology; Clearside Biomedical; Karyopharm Therapeutics; Mersana
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Exact Sciences; Gilead Sciences; Lilly; Menarini Group; MSD; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; Menarini Group; MSD; Novartis; Pfizer; Roche
Research Funding - Daiichi Sankyo/Astra Zeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; Novartis; Pfizer; Roche
 
Giuseppe Curigliano
Leadership - ESMO; ESMO; ESMO Open; European Society of Breast Cancer Specialists (EUSOMA=
Honoraria - Ellipses Pharma
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celcuity; Daichi-Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; GlaxoSmithKline; Guardant Health; Hengrui Therapeutics; Lilly; Menarini; Merck; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen; Veracyte
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daichii Sankyo; Pfizer; Roche/Genentech
 
Angela Toss
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Seagen
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; MSD/AstraZeneca; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences
 
Andrea Botticelli
No Relationships to Disclose
 
Rebecca Pedersini
No Relationships to Disclose
 
Saverio Cinieri
No Relationships to Disclose
 
Matteo Lambertini
Honoraria - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Ipsen; Libbs; Lilly; Menarini; Novartis; Pfizer; Roche; Sandoz; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; Exact Sciences; Gilead Sciences; Ipsen; Lilly; Menarini; MSD; Nordic Bioscience; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Roche
 
Barbara Tagliaferri
Honoraria - Daiichi Sankyo,; Lilly; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo.; Novartis; Pfizer; Roche
 
Gianpiero Rizzo
No Relationships to Disclose
 
Marianna Sirico
No Relationships to Disclose
 
Monica Giordano
Honoraria - AstraZeneca; Daiichi Sankyo; Lilly; Novartis
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Pfizer
 
Lorenzo Gerratana
Consulting or Advisory Role - Abbvie; AstraZeneca; Daiichi Sankyo; GlaxoSmithKline; Incyte; Lilly; Menarini Group; MSD; Novartis; Pfizer
Research Funding - Menarini Silicon Biosystems (Inst)
Travel, Accommodations, Expenses - Menarini Group
 
Icro Meattini
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Lilly; Novartis; Pfizer; Pierre Fabre; SeaGen
 
Francesco Pantano
No Relationships to Disclose
 
Alessandra Gennari
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Stemline Therapeutics
Research Funding - Pharmanutra (Inst)
 
Giacomo Mazzoli
No Relationships to Disclose